Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Pediatric Pulmonology|August 4, 2022
Plasma and cellular ivacaftor concentrations in patients with cystic fibrosisJennifer S Guimbellot, Kevin J Ryan, Justin D Anderson, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 12, 2020
Variable cellular ivacaftor concentrations in people with cystic fibrosis on modulator therapyJennifer S Guimbellot, Kevin J Ryan, Justin D Anderson, et al.AIDS (London, England)|July 14, 2018
HIV RNA persists in rectal tissue despite rapid plasma virologic suppression with dolutegravir-based therapyCecile D Lahiri, Nakita L Brown, Kevin J Ryan, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 16, 2021
Ivacaftor-elexacaftor-tezacaftor and tacrolimus combination in cystic fibrosisMegan Smith, Kevin J Ryan, Hector Gutierrez, et al.Pulmonary Pharmacology & Therapeutics|July 4, 2024
Differential distribution of ivacaftor and its metabolites in plasma and human airway epitheliaZhongyu Liu, Justin D Anderson, Natalie R Rose, et al.Frontiers in Pharmacology|June 1, 2022
Systemic Administration of a Brain Permeable Cdk5 Inhibitor Alters NeurobehaviorAlan Umfress, Sarbjit Singh, Kevin J Ryan, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 13, 2022
Quantitation of cystic fibrosis triple combination therapy, elexacaftor/tezacaftor/ivacaftor, in human plasma and cellular lysateKevin J Ryan, Jennifer S Guimbellot, Alexander E Dowell, et al.Hypertension (Dallas, Tex. : 1979)|March 18, 2009
Angiotensin I is largely converted to angiotensin (1-7) and angiotensin (2-10) by isolated rat glomeruliJuan Carlos Q Velez, Kevin J Ryan, Caroline E Harbeson, et al.The European Respiratory Journal|February 19, 2026
Impact of CFTR Modulator Concentrations on Clinical Response in Cystic FibrosisAshritha R Chalamalla, Elizabeth Baker, Kevin J Ryan, et al.Jac-Antimicrobial Resistance|December 11, 2024
Evaluating the effects of ivacaftor exposure on <i>Staphylococcus aureus</i> small colony variant development and antibiotic toleranceGretchen E Bollar, Kendall M Shaffer, Johnathan D Keith, et al.Pageof 3